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INTRODUCTION
Intestinal homeostasis is achieved in part by the maintenance of a
functional barrier composed of a single layer of intestinal epithelial
cells (IEC), which separates the host from the highly antigenic
lumenal milieu (Sartor, 2008). Events leading to compromised
barrier function are associated with various intestinal disorders
including inflammatory bowel diseases (IBD) (Williams et al., 2001;
Sartor, 2008). Conditions leading to an impaired mucosal barrier
function are diverse and include medications (non-steroidal anti-
inflammatory drugs or NSAIDs) (Morteau et al., 2000), radiation
exposure (Packey and Ciorba, 2010), ischemic episodes (Kinross et
al., 2009) and genetic predisposition (Sartor, 2008). Notably, genes
that disrupt the unfolded protein response (UPR) and autophagy
following cellular stress have recently been implicated in the
pathogenesis of IBD (Kaser et al., 2010; Stappenbeck et al., 2011).
The disease etiology remains unclear; however, genetic evidence
and experimental models suggest that intestinal cell death due to
improper responses to endoplasmic reticulum (ER) stress leads to
impaired barrier function (Kaser et al., 2008). Because of the
importance of the epithelium in maintaining intestinal homeostasis,
understanding mechanisms involved in intestinal epithelial healing
and cell stress responses, and the identification of compounds that
promote these processes, could lead to new therapeutic strategies
for IBD.
Epithelial barrier damage triggers a host response termed
‘restitution/wound-healing’ (Karrasch and Jobin, 2009). In this
response, cells at the wound edge migrate into the wounded area,
undergo cytoskeletal rearrangement and finally re-establish tight
junction barriers with their neighboring cells (Karrasch and Jobin,
2009; Marchiando et al., 2011). This initial phase does not require
epithelial proliferation, but renewal of cells are needed to replenish
the decreased enterocyte pool after injury (Karrasch and Jobin,
2009). Various pathways including nuclear factor kappa-light-
chain-enhancer of activated B cells (NF-B), mitogen-activated
protein kinase (MAPK), signal transducer and activator of
transcription 3 (STAT3), glycogen synthase kinase-3 (GSK3)/-
catenin (Kim and Jobin, 2010) and phosphatidylinositol 3-kinase
(PI3K)/Akt (Karrasch and Jobin, 2009) are involved in the wound
healing response through a combination of pro-migratory,
proliferative and/or anti-apoptotic activities. The -opioid receptor
(MOR) ligand DALDA has also recently been shown to activate
the intestinal wound healing response in mice (Goldsmith et al.,
2011). However, the mechanism of MOR-mediated protection is
largely unknown at this point.
The wide array of upstream signals and downstream pathways
has made the study of restitution/wound healing a complex and
difficult area of research (Karrasch and Jobin, 2008; Karrasch and
Jobin, 2009). The vast majority of our information on this complex
process is derived from rodent models, which have limited capacity
for imaging techniques and therapeutic investigation (Wirtz et al.,
2007). Zebrafish (Danio rerio) possess several features that make it
an attractive model for in vivo investigation of intestinal injury.
Zebrafish are transparent through early adulthood, allowing the use
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SUMMARY
Beside their analgesic properties, opiates exert beneficial effects on the intestinal wound healing response. In this study, we investigated the role
of -opioid receptor (MOR) signaling on the unfolded protein response (UPR) using a novel zebrafish model of NSAID-induced intestinal injury. The
NSAID glafenine was administered to zebrafish larvae at 5 days post-fertilization (dpf) for up to 24 hours in the presence or absence of the MOR-
specific agonist DALDA. By analysis with histology, transmission electron microscopy and vital dye staining, glafenine-treated zebrafish showed
evidence of endoplasmic reticulum and mitochondrial stress, with disrupted intestinal architecture and halted cell stress responses, alongside
accumulation of apoptotic intestinal epithelial cells in the lumen. Although the early UPR marker BiP was induced with glafenine-induced injury,
downstream atf6 and s-xbp1 expression were paradoxically not increased, explaining the halted cell stress responses. The -opioid agonist DALDA
protected against glafenine-induced injury through induction of atf6-dependent UPR. Our findings show that DALDA prevents glafenine-induced
epithelial damage through induction of effective UPR.
Glafenine-induced intestinal injury in zebrafish is
ameliorated by -opioid signaling via enhancement of
Atf6-dependent cellular stress responses
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of in vivo imaging techniques. Furthermore, the anatomy and
physiology of their digestive tract is similar to that of mammals, with
a pancreas, liver, gall bladder and intestine (Pack et al., 1996; Ng et
al., 2005; Wallace et al., 2005). The zebrafish intestinal epithelium
displays proximal-distal functional specification and contains most
of same cell lineages found in mammals, including absorptive
enterocytes, goblet cells and enteroendocrine cells (Ng et al., 2005;
Wallace et al., 2005). The zebrafish digestive tract develops rapidly
to permit feeding and digestive function by 5 days post fertilization
(dpf). Zebrafish also possess innate and adaptive immune systems
homologous to those of mammals (Meeker and Trede, 2008; Kanther
and Rawls, 2010). Previous studies have attempted to establish models
of intestinal injury in zebrafish larvae by immersion in the hapten
2,4,6-trinitrobenzene sulfonic acid (TNBS) or with the use of the
detergent dextran sodium sulfate; however, these models lack overt
pathological changes to the intestinal tract based on histology, and
the inflammation and injury produced is not intestine-specific
(Fleming et al., 2010; Oehlers et al., 2011; Oehlers et al., 2012).
Here, we describe a novel larval zebrafish model of acute
intestinal injury using the NSAID glafenine. NSAIDs are known
to disrupt the intestinal epithelium, leading to ulceration and
inflammation in both humans and in mice (Morteau et al., 2000;
Maiden et al., 2005). Additionally, zebrafish have homologs for both
cyclooxygenase (COX) isoforms (the targets of NSAIDs) that
function similarly and display the same responses to prototypical
pharmacological inhibitors as seen in mammals (Grosser et al.,
2002). Our work establishes that administration of glafenine larvae
for 1-12 hours results in profound intestinal injury, with limited
evidence of damage in extra-intestinal locations. Immersion in
glafenine resulted in intestinal epithelial cell (IEC) apoptosis and
sloughing due to induction of ER stress combined with inhibition
of appropriate compensatory UPR responses. In contrast to
previous reports of TNBS injury in the zebrafish (Fleming et al.,
2010; Oehlers et al., 2011), the glafenine-induced injury model
shows profound pathological changes to the intestine and appears
to be specific to the gastroenterological system. We demonstrate
for the first time that MOR signaling induces the UPR signals to
enhance restitution, thereby protecting against glafenine-induced
intestinal injury.
RESULTS
Glafenine administration produces cellular sloughing comprising
apoptotic IECs
NSAIDs induce gastrointestinal damage in both humans and mice
through COX blockade (Morteau et al., 2000; Maiden et al., 2005).
In an effort to develop a zebrafish model of gastrointestinal injury,
we exposed zebrafish larvae at 5.5 dpf to a panel of NSAIDs for 12
hours (supplementary material Fig. S1A). Administration of Sc-560
(COX-1) (Teraoka et al., 2009), Ns-360 (COX-2) (Grosser et al.,
2002) or indomethacin (non-specific) (Grosser et al., 2002) all failed
to generate a visible intestinal phenotype, using maximum tolerable
dosages that did not result in a rate of death ≥50% (data not shown).
Furthermore, combined administration of Sc-560 and Ns-360
resulted in 100% death (data not shown). However, administration
of the non-specific NSAID glafenine induced the formation of an
opaque, impacted intestinal lumen extending from the distal part
of segment 1 through segment 3, with the production of a visible
‘tube’ of material extending from the cloaca (Fig. 1A, white
arrowheads). Dose titration studies revealed that administration of
25 M glafenine for 12 hours produced the highest level of tube
formation with minimal zebrafish death (supplementary material
Fig. S1B).
Because of the documented role of prostaglandins in IEC
survival (Morteau et al., 2000), we speculated that the impacted
lumen was composed of expulsed dead IECs. To test whether cells
in the lumenal mass were still alive, we exposed untreated and
glafenine-treated zebrafish to the vital dye Acridine Orange (AO)
for 30 minutes and imaged them by fluorescence microscopy. An
intense streak of AO-positive cells in the lumen of glafenine-
exposed fish could be observed by both wide-field and confocal
microscopy (Fig. 1B), suggesting the presence of cellular entities.
The mass extending from the cloaca observed by brightfield
microscopy (Fig. 1A) was also AO-positive, suggesting that dead
cells are expelled from the distal intestine through the cloaca.
Analysis of relative AO fluorescence in the intestinal lumen
revealed a 2.2-fold increase in glafenine-treated fish compared
TRANSLATIONAL IMPACT
Clinical issue
Damage to the intestinal epithelium is involved in numerous intestinal
pathologies, such as ischemia-reperfusion injury, radiation injury and
inflammatory bowel diseases (IBDs). Study of the mechanisms involved in
intestinal injury and wound healing, and the development of therapeutics
designed to enhance intestinal epithelial wound healing, are limited by the
paucity of appropriate model systems. Currently available experimental
platforms use rodent models with significant associated costs and time
constraints. Zebrafish are an attractive alternative model organism for such
studies: they have a digestive system similar to that of mammals, their optical
transparency allows for the use of powerful in vivo imaging modalities, and
their small size permits high-throughput genetic and chemical tests.
Results
Among many proposed agents that cause injury to intestinal epithelial cells
(IECs) are non-steroidal anti-inflammatory drugs (NSAIDs). Here, the authors
developed a larval zebrafish model of intestinal injury by administering the
NSAID glafenine to zebrafish for up to 12 hours. The resulting pathology is
characterized by rapid (within 1 hour of drug administration) IEC apoptosis
that leads to sloughing of the cells into the intestinal lumen. Ultra-structure
analysis showed that the IECs of glafenine-injured fish showed signs of
endoplasmic reticulum (ER) stress and atypical, halted cell stress responses.
The sloughing cells form a visible ‘tube’ of material, which can be labeled using
the vital dye AO. Using a rapid assay to detect the presence of this tube, the
authors screened several compounds for amelioration of IEC apoptosis. Of
interest, the -opioid receptor (MOR) agonist DALDA markedly reduced tube
formation. Further studies demonstrated that DALDA treatment drastically
reduced IEC apoptosis and restored proper organelle stress responses. Finally,
knockout of the autophagy gene atf6 resulted in loss of DALDA protection,
suggesting that DALDA protects from glafenine-mediated intestinal injury by
inducing an atf6-dependent unfolded protein response (UPR).
Implications and future directions
This work establishes the first model of larval zebrafish intestinal injury, and
shows that it can be used to screen for compounds that protect against it.
Additionally, the glafenine-induced injury model recapitulates the recently
discovered relationship between improper organelle stress responses and IEC
apoptosis in another organism, demonstrating conservation of this
phenomenon across species. Finally, this work establishes a novel mechanism
for MOR-mediated protection from intestinal injury and suggests that opioids,
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with untreated controls (Fig. 1C). Histological assessment of serial
sections revealed marked intestinal sloughing into the lumen in
segment 1, whereas segment 2 was characterized by an impacted
lumen with pyknotic epithelial nuclei, cellular
hypertrophy/hyperplasia and apical/sloughing nuclei (Fig. 1D;
supplementary material Fig. S2B-E). All of these phenotypes are
signs of cellular damage and apoptosis. Blinded, histological
scoring of segment 2 sections showed a statistically significant
increase in cellular damage in glafenine-treated fish compared
with control (8.8 compared with 2.6; Fig. 1E). In addition, an
increase in activated caspase-3-positive cells was observed in the
epithelium (segment 1) and lumenal debris (segments 1 and 2)
of glafenine-treated fish but not untreated fish (Fig. 1F). This
staining was not seen using IgG control antibody (supplementary
material Fig. S2F). By contrast, caspase-3 staining was virtually
absent in the liver of glafenine-treated zebrafish (Fig. 1F, encircled
in white). Together, these findings suggest that glafenine treatment
induces cellular apoptosis in the intestine.
We next performed kinetic analysis of glafenine-induced
intestinal injury. To facilitate this, we developed a rapid assay for
apoptosis and/or injury (see Methods) using AO staining. We
observed that glafenine induced epithelial injury and apoptotic
tubes in about 50% of zebrafish as early as 3 hours, which increased
to ~90% of fish after 12 hours of exposure (Fig. 2A). Histological
analysis of segment 2 after 3 hours of glafenine exposure confirmed
the presence of injured epithelial cells (Fig. 2B). Additionally,
marked intestinal sloughing was found in segment 1 after 3 hours
(Fig. 2C) and this feature persisted through 12 hours of treatment
(Fig. 1D). Histological analysis of the liver after 3, 6 and 12 hours
of glafenine exposure showed minimal cellular damage that could
be at best described as hydropic changes, maximally seen at 6 hours
(Fig. 2D). To determine whether glafenine is still bioactive after
long-term treatment (12 hours), media-swapping studies were
performed where a new, untreated cohort of zebrafish were
introduced into medium in which a different group of zebrafish
had been exposed to glafenine for 12 hours. The conditioned media
Fig. 1. Glafenine results in apoptotic cell death
with sloughing and dysmorphic cellular
architecture. (A-F)All studies were made after 12
hours of glafenine exposure in 5 dpf zebrafish.
(A)Lumenal sloughing is apparent on brightfield
microscopy. Segments 1-3 of the intestine are
bracketed and labeled. Arrowheads show sloughing
from the intestine. Scale bar: 1 mm. (B)AO staining
shows apoptotic lumenal and sloughing debris.
Blue arrowheads point to enterocytes that auto-
fluoresce red; white arrowheads point to apoptotic
lumenal and extruded debris. Scale bars: 1 mm for
wide-field images, 50m for confocal images.
(C)Apoptotic mass can be detected by differences
in relative AO fluorescence. Representative of four
independent experiments, n≥4 per experiment.
(D)H&E sections showing glafenine-induced injury.
Regions of liver are encircled with white dashes
(segment 1). The apical surface of the intestinal
epithelium is outlined in white (segment 2). Arrows
point to sloughed cellular debris and arrowheads
point to nuclei. Scale bars: 50m. (E)Segment 2
histological scores, pooled from three independent
experiments; n for each group is indicated on the
graph. (F)Activated caspase-3
immunohistochemistry. The apical surface of the
intestinal epithelium is outlined in white dots.
Regions of liver are encircled by a solid white line.
Arrowheads point to positively staining IECs; M,
melanocytes; Liv, liver. Scale bars: 50m for
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did not lead to AO-positive tubes in the new group of fish (data
not shown). These data demonstrate that glafenine-induced injury
occurs acutely and that the drug is no longer active after 12 hours.
To identify the cellular origins of the damaged cells, we
performed transmission electron microscopy (TEM) ultrastructural
analysis of glafenine-treated fish. The apoptotic tubes observed
macroscopically in glafenine-exposed fish comprised cellular debris
and multiple, distinctively apoptotic IECs within the epithelium of
segments 1 and 2 and in the lumen of segment 2 (Fig. 3A),
confirming that the caspase-3 and AO signals described earlier were
due to apoptosis. Debris consistent with microvilli vesiculation, a
hallmark of apoptotic cell shedding (Marchiando et al., 2011), was
also observed only in injured zebrafish (Fig. 3B). In addition, IECs
of glafenine-exposed zebrafish showed features of ER stress with
pitted ER in intestinal segments 1 and 2, which was most
pronounced after 3 hours of glafenine exposure (Fig. 3C). Further
kinetic analysis revealed increasing signs of ER and mitochondrial
stress over time, from 1-12 hours of exposure (Fig. 4A,B). Early
signs of ER stress peaked at 3 hours, whereas organelle stress (along
with apoptosis) steadily increased up to 12 hours after initial
exposure; however, despite the fact that restitution of cell stress
appeared to be initiated, most organelles were not fully enveloped
by membrane, indicating that the cellular stress responses processes
were in the early stages (Fig. 4A,B).
To determine whether glafenine-induced IEC apoptosis was
associated with reductions in epithelial barrier function, we gavaged
zebrafish with Texas Red (TxR)-labeled 10 kD dextran and
monitored extra-intestinal fluorescence (Cocchiaro and Rawls,
2012). Strikingly, extra-intestinal fluorescence in zebrafish treated
with glafenine for 1 or 3 hours was low and indistinguishable from
untreated controls (Fig. 5A,B). By contrast, positive control
treatment groups co-gavaged with TxR-dextran and 20 mM EDTA
displayed infiltration of TxR-dextran into intersomitic spaces and
circulation (Fig. 5A). These results suggest that glafenine treatment
alone does not robustly compromise epithelial barrier function
during acute damage when the drug is most active. TxR-dextran
gavage after 12 hours of glafenine exposure exhibited similar
results (data not shown).
Because glafenine has been reported to cause anaphylaxis in
humans, as well as liver damage (Stricker et al., 1990; van der Klauw
Fig. 2. Progressive glafenine-induced injury over 0-12
hours is centered on the intestine. (A)AO-positive tube
formation, n≥13. (B)Segment 2 histological score, n≥9. The 0
and 12-hour time points are recapitulated from Fig. 1.
(C)Histology at 3 hours. (D)H&E sections of livers of zebrafish
exposed to 0, 3, 6 and 12 hours of glafenine. Mild hydropic
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et al., 1993), we determined the impact of glafenine in extra-
intestinal sites. Importantly, no changes were observed in the skin
or musculature of glafenine-treated fish, suggesting a
predominantly gastrointestinal phenotype (Fig. 6). This was
confirmed by AO staining, which revealed no effects of glafenine
treatment, except in the liver (Fig. 7). However, histological analysis
and caspase-3 staining failed to document evidence of
hepatocellular damage or death (Figs 1, 2). Together, these data
suggest that glafenine causes minimal liver damage. Additionally,
we noticed no gross bleeding into the intestine in control and
glafenine-exposed Tg(gata1:dsRed)sd2;(kdr1:EGFP)s843 fish, with all
dsRed-labeled red blood cells overlapping the EGFP-labeled
vasculature (supplementary material Fig. S3A,B). Together, these
data suggest a gastrointestinal-specific phenotype, with damage
most specific to the intestinal tract.
The -opioid agonist DALDA protects against glafenine-induced
injury
Because apoptosis is an important feature of our model, we
investigated the impact of anti-apoptotic, pro-proliferative, and/or
pro-migratory compounds on glafenine-induced injury using the
formation of AO-positive tubes as a rapid screening assay. We
identified several compounds that conferred protection against
glafenine-induced injury when added to the housing medium. R-
spondin1 (a -catenin activator), the MOR agonist DALDA, the
COX-2 derivative product dmPGE2 and the pan-caspase inhibitor
Q-VD-OPh all afforded significant protection (Fig. 8A). These
compounds all share the characteristic of engaging anti-apoptotic
or pro-survival signaling pathways (Zhao et al., 2007; Ootani et al.,
2009; North et al., 2010; Goldsmith et al., 2011). By contrast, the
mitogenic factors human insulin-like growth factor (hIGF1) and
mouse epidermal growth factor (mEGF) failed to protect against
glafenine-induced injury. Together, these data suggest that only a
subset of pro-survival, anti-apoptotic signals are protective in this
model. We hypothesized that mitigation of organelle stress was the
common factor in the effect of the drugs that reduced glafenine-
mediated AO tube formation.
Given the recent discovery of the intestinal-protective effects of
-opioid signaling (Goldsmith et al., 2011), we decided to further
investigate the effect of this opiate on intestinal injury in this
zebrafish model. Co-administration of the opioid inhibitor
Naloxone (1 mM) alongside DALDA treatment abolished DALDA-
mediated protection as determined by the tube assay (data not
shown), demonstrating that protection by DALDA was mediated
through MOR signaling. Histological assessment of DALDA-
treated, glafenine-exposed fish showed a ~45% decrease in intestinal
damage compared with untreated glafenine-exposed animals (Fig.
8B). In addition, glafenine-induced zebrafish mortality was
improved by about twofold by DALDA treatment (Fig. 8C). Because
apoptosis plays a central role in this injury model, we determined
the level of activated caspase-3 staining in the intestinal tissues of
zebrafish co-treated with glafenine and DALDA. In accordance with
Fig. 3. TEM identifies the apoptotic cells as intestinal
epithelial in origin. (A-C)TEM images, representative of two
separate fish, across multiple sections after 12 hours of
glafenine exposure. 5000 magnification; scale bars: 2m.
(A,B)Samples fixed after 12 hours of exposure. (C)Images taken
after 3 hours of exposure to glafenine. (A)Ultrastructure
architecture of control and glafenine-injured fish in segments 1
and 2 of the intestinal epithelium. Apoptotic IECs (white arrow
in segment 1) and lumenal cellular debris (white arrows in
segment 2) can be observed. Brush border is indicated by black
arrows. (B)Lumenal debris seen with glafenine-induced injury in
segment 1, which is consistent with microvesiculation of
intestinal brush border. (C)ER stress in segment 2, with
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decreased AO tube formation and improvement of animal survival,
DALDA sharply reduced the amount of activated caspase-3 staining
in the intestine compared with fish exposed only to glafenine (Fig.
8D). Additionally, DALDA treatment enhanced epithelial cell
proliferation during glafenine-induced injury about twofold, as
measured by EdU incorporation (Fig. 8E).
Opioid signaling overcomes glafenine-induced blockade of
organelle stress response genes, allowing cell survival
Because DALDA amelioration of glafenine-induced intestinal injury
is associated with decreased apoptotic markers, we speculated that
protection by DALDA is mediated by either preventing the
observed organelle stress and/or by increasing compensatory
responses such as the UPR that can ward off apoptosis in the
presence of cell stress. Interestingly, more organelle stress was
present (although diminished) in zebrafish treated with DALDA
than with glafenine-induced injury alone (Fig. 9A). DALDA-treated
zebrafish maintained an organized epithelium without basement
membrane invagination, and organelles did not appear swollen or
lacking in sub-organelle architecture. ER stress, as indicated by
pitting white lesions, was not prominent in DALDA-treated fish.
Also, increased smooth ER and re-establishment of subcellular
structures was apparent, presumably the result of resolving cell
stress response (Fig. 9A). IECs in the DALDA-treated group also
displayed enhanced rough ER (Fig. 9B), a typical sign of resolving
cell stress because resolution requires increased protein synthesis.
Given the presence of ER and organelle stress, we investigated
the downstream proteins and genes of the UPR cascade. Protein
levels of the early UPR mediator BiP were similar in lysates from
whole fish exposed to glafenine with or without DALDA (Fig. 9C).
By contrast, eIF2a phosphorylation, which is downstream of PERK
activation, could not be detected (data not shown). Quantitative
RT-PCR assays using microdissected digestive tracts demonstrated
that two UPR genes normally upregulated downstream of BiP
accumulation, spliced-xbp1 (s-xbp1) and atf6 (Shen et al., 2005;
Cinaroglu et al., 2011), were atypically not upregulated in glafenine-
exposed compared with untreated fish, although these genes were
induced in DALDA-treated fish (Fig. 9D). These results were
recapitulated using whole larvae lysates (supplementary material
Fig. S4A), and DALDA was able to drastically induce these genes
in the absence of glafenine-induced injury and inhibition
(supplementary material Fig. S4B). Because atf6 is a key mediator
of organelle stress responses, leading to the UPR, we next
determined the functional role of this gene in DALDA-mediated
protection from injury. Zebrafish injected with atf6-morpholino
(MO) displayed abrogation of DALDA-mediated rescue of
Fig. 4. Glafenine leads to ER stress and arrested cell stress
responses. (A,B)Zebrafish larvae at 5.5-6 dpf were exposed to
glafenine for the indicated times. Black arrows point to ER stress
evidenced by pitting. Dashed circles outline stressed organelles
being enveloped by membrane. Solid circles outline dead
organelles. White arrowheads point to basement membrane
invagination; white arrowhead with dashed line points to
stressed mitochondria. Scale bars: 1m. (A)Lower magnification















    




Glafenine intestinal injury in zebrafishRESEARCH ARTICLE
glafenine-induced injury compared with animals injected with
control MO (Fig. 9E), suggesting that enhancement of the UPR
response mediates DALDA rescue of glafenine-induced injury.
DISCUSSION
Recent studies in mice and in human patients have implicated
improper IEC autophagy and UPR in the face of ER stress as a
potential etiology for IBD (Kaser et al., 2008; Kaser et al., 2010;
Stappenbeck et al., 2011). In this study, we recapitulate this IEC
apoptosis in the zebrafish using the NSAID glafenine, an inhibitor
of both COX isoforms that was withdrawn from the market after
phase IV studies showed that the drug results in anaphylaxis and
gastrointestinal disturbances in human patients (Stricker et al.,
1990). Current murine models for studying ER-stress-induced IEC
damage require the production of genetic knockouts. This zebrafish
model provides several advantages over those systems, including
the use of chemical induction and the ease of live imaging and
screening for intestinal damage phenotypes. This is also the first
larval zebrafish model to demonstrate marked intestinal pathology,
namely IEC apoptosis. Previous reports only presented vague
systemic inflammatory infiltration without overt changes in the
intestinal epithelium (Fleming et al., 2010; Oehlers et al., 2011;
Oehlers et al., 2012).
We present several lines of evidence indicating that the NSAID
glafenine induces IEC apoptosis by enhancing ER stress, while
interfering with compensatory rescue UPR (Fig. 10). First, TEM
revealed ER pitting shortly after glafenine exposure (1-3 hours), a
hallmark of ER stress. After extended glafenine exposure (12
hours), IECs displayed features that indicated an arrested cell stress
response, including partially enveloped organelles and numerous
swollen, stressed organelles in living epithelial cells alongside many
distinctively apoptotic cells. Secondly, induction of UPR-associated
genes atf6 and s-xbp1 are impaired in glafenine-exposed fish.
Finally, the presence of activated caspase-3-positive apoptotic cells
in both intestinal epithelium and the lumenal compartment of
glafenine-treated fish are consistent with a failure to adequately
respond to cellular stress (Codogno and Meijer, 2005; Kaser et al.,
2008; Kaser et al., 2010; Franceschelli et al., 2011). These findings
suggest that glafenine induces a strong IEC stress phenotype that
translates into increased cellular apoptosis and epithelial damage.
Although some liver damage probably exists, the intestinal
phenotype is far more pronounced. Additionally, our TEM analysis
Fig. 5. Intestinal epithelial barrier leakage does not occur
with acute glafenine treatment. (A,B)Zebrafish larvae at 6 dpf
were pretreated with glafenine or vehicle control for 1 or 3
hours, followed by gavage with 1% TxR-dextran or 1% TxR-
dextran plus 20 mM EDTA (positive control). ImageJ was used to
quantitate the relative mean fluorescence in an ROI in the
zebrafish larvae trunk above segments 2 and 3 of the intestine
(white dashed rectangles). Values were normalized to an ROI
outside of the fish as an internal control to account for
background glare. (A)Dextran leaks into circulation and
intersomitic spaces when co-gavaged with EDTA.
Representative images of larvae from the 1-hour pretreatment
group are shown. In larvae gavaged with dextran only, the
dextran remains in the intestinal lumen. When co-gavaged with
dextran plus EDTA, fluorescent signal is observed in circulation
(dorsal aorta, white arrow) and intersomitic vessels and spaces
(white arrowheads). BF, brightfield. Scale bars: 200m.
(B)Treatment with glafenine does not lead to acute intestinal
barrier disruption. Mean normalized fluorescence in the trunk
was determined following 1 or 3 hours of pretreatment with
glafenine or control. Graph represents data averaged from two
experimental replicates taking into account the mean, s.d. and n
(16-19 larvae/condition/experiment). Two-way ANOVA with
Bonferroni post-test was performed to compare each column to
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and AO staining studies, alongside the use of an NF-B reporter
strain to assess tissue-specific NF-B activity (supplementary
material Fig. S5) (Kanther et al., 2011) showed a gastrointestinal-
specific phenotype, another strength of this model.
Interestingly, despite the observed IEC apoptosis, the epithelial
barrier remains intact. Using TxR-labeled dextran and oral gavage,
we observed that the dextran does not leak out of the intestine in
glafenine-treated zebrafish. This suggests that glafenine-induced
apoptosis is highly controlled and results in cell shedding with
maintenance of the epithelial barrier. Our TEM results support
these findings, demonstrating the presence of shedding apoptotic
IECs in the epithelial border with maintenance of the barrier by
Fig. 6. TEM studies show that glafenine-induced injury keeps the
skin and musculature intact. TEM images, representative of three
separate fish, after 12 hours of glafenine exposure. 2500
magnification. Scale bars: 2m.
Fig. 7. Glafenine-induced injury is specific to the
gastrointestinal system. AO staining marks
apoptotic cells throughout the fish. Studies were
performed after 12 hours of glafenine exposure.
Representative control and glafenine-treated fish are
shown, with the regions analyzed shown on the
glafenine image. Values are representative of three
independent experiments, n≥4 fish/experiment/
condition; *P<0.05. SB, swim bladder; Liv, liver; DF,
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cells basal to the dying cell, together forming the characteristic Y-
pattern of controlled cell shedding (Marchiando et al., 2011).
Additionally, glafenine treatment of zebrafish larvae has previously
been shown to cause increased activity of digestive enzymes
phospholipase and protease within the intestinal lumen (Hama et
al., 2009). Our results provide a potential physiological explanation
for this observation: that these and other enzymes are released
promiscuously from apoptotic IECs after glafenine exposure.
Although our kinetic and media-swapping studies suggest that
glafenine-induced injury is rapid and acute, the mechanism by
which glafenine induces epithelial-specific stress responses and
damage is uncertain.
Intestinal epithelium damage is a well-known effect of COX
inhibitors (Morteau et al., 2000; Maiden et al., 2005). NSAIDs
decouple mitochondrial oxidative phosphorylation within 1 hour
of administration (Somasundaram et al., 2000), resulting in ER and
general cell stress that in the highly energy-dependent enterocyte
can lead to cellular death. In our model, TEM showed characteristic
mitochondrial vacuolization typical of NSAID-induced
mitochondrial injury, suggesting that this could be the mechanism
of injury in our model. Previous, in vitro only, studies demonstrated
that other NSAIDs induce apoptosis through improper ER stress
responses (Franceschelli et al., 2011), also suggesting that the effects
of glafenine observed here are a result of its COX-inhibitory
properties. The fact that dmPGE2 rescues zebrafish from IEC
apoptosis in this model supports this notion. The observation that
other NSAIDs were unable to recapitulate the injury caused by
glafenine suggests that these inhibitors, as opposed to glafenine,
mainly cause extra-intestinal-mediated mortality over intestinal
injury. This is compatible with our observation that zebrafish
treated with other NSAIDs died before development of any
intestinal apoptosis. In summary, we postulate that IECs are unable
to appropriately response to glafenine-induced ER stress and as a
result undergo rapid and but orderly apoptosis.
Fig. 8. Glafenine-induced injury can be prevented with a subset of anti-apoptotic and/or pro-survival drugs, including the MOR agonist DALDA. (A-E)All
studies performed after 12 hours of drug(s) exposure. (A)Rapid apoptosis assays show that glafenine-induced injury can be prevented by drugs that engage pro-
survival and/or anti-apoptotic signaling, but not solely proliferative signalling; n≥15 per group. Control, glafenine and glafenine + DALDA results are all
representative of three or more independent experiments; dmPGE2 results are representative of two independent experiments; other drugs results are
representative of replicate experiments performed on the same day with different groups of larvae. Significance shown is relative to glafenine treatment alone;
P<0.001 between control and glafenine groups (not shown on graph); n for each group is represented on the graph. Dosages: 10M dmPGE2, 250 ng/ml hIGF1,
10 nM mEGF and R-spondin, 50M Q-VD-Oph. (B)Segment 2 histological scores. Control and glafenine groups are recapitulated from Fig. 1, for ease of
comparison with DALDA treatment. (C)DALDA enhances zebrafish survival from glafenine-induced injury. n50, pooled from three independent experiments.
Glafenine was used at 50M final concentration. (D)Activated caspase-3 immunohistochemistry staining in the intestinal epithelium. Representative of four fish
per group. The lumenal edge is outlined in white; M, melanocytes. Scale bars: 12.5m. (E)Proliferation in segment 2 in response to drug treatment. White arrow
shows hyperplastic cells seen with DALDA administration. Scale bars: 50m. Graph shows EdU staining of zebrafish with 12 hours of drug exposure for each
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Neuropeptides have attracted interest as a means to modulate
intestinal inflammation and to promote epithelial restitution
(Philippe et al., 2003). We recently showed that the MOR agonist
DALDA protects against DSS-induced intestinal injury through
wound healing and proliferative responses in mice (Goldsmith et
al., 2011). DALDA promoted intestinal proliferation in glafenine-
exposed fish consistent with the previously reported properties of
the drug (Goldsmith et al., 2011). However, other zebrafish bioactive
proliferative factors (mEGF and hIGF1) (Pozios et al., 2001; Pang
and Ge, 2002) failed to prevent glafenine-induced injury, suggesting
that proliferation is not the primary protective mechanism of
DALDA in this model.
Interestingly, our study identifies a novel means by which -opioid
signaling might protect against acute epithelial injury. TEM and
biochemical analysis of DALDA-treated fish showed decreased
organelle stress as well as enhanced UPR, leading to reduced cellular
apoptosis and maintenance of epithelial layer integrity. Our studies
showed that DALDA enhances atf6 and s-xbp1 mRNA expression
in zebrafish both in the presence and absence of glafenine, and that
the protective effects of DALDA were lost in zebrafish lacking atf6
function. We therefore conclude that MOR signaling enhances
proper cell stress and UPR responses, a previously unknown
mechanism of neuropeptide-mediated intestinal protection. At least
one important cell stress response pathway, the PI3K pathway
(Codogno and Meijer, 2005), is directly activated by MOR signaling
(Law et al., 2000), providing a potential mechanism for the action of
DALDA in this zebrafish model. To support this hypothesis, addition
of the PI3K inhibitor wortmannin resulted in complete loss of
DALDA-mediated protection (data not shown). An important
consequence of organelle stress is autophagy, which is initiated both
downstream of PI3K activation and as a result of the UPR. The role
of both systems in our work suggests that glafenine-induced blockade
of the UPR could result in diminished autophagy and enhanced cell
death, a process reversed by DALDA. Further studies should be
pursued to evaluate the role of autophagy in our glafenine system
and the effect of DALDA on the autophagic process.
Fig. 9. DALDA reverses glafenine-
induced organelle stress and restores
proper UPR responses. (A-E)All
zebrafish studies were performed after
of 12 hours glafenine exposure. (A)TEM
with and without DALDA treatment
demonstrates a lack of ER and organelle
stress and resolved UPR. White
arrowheads show pitting from ER stress.
White arrow demarks apoptotic IEC.
Black arrowheads indicate the brush
border. Scale bars: 2m. (B)Same
conditions as for A, showing granularity
in the cytoplasm of segment 1 IECs,
indicative of rough ER. Scale bar:
0.5m. (C)Glafenine-induced injury
causes BiP protein accumulation, an
early signal in the UPR cascade. Western
blot representative of four independent
experiments, each consisting of protein
lysate from ≥10 pooled fish per
condition. -actin was used as loading
control. (D)Real-time PCR for UPR
genes: u-xbp1 (unspliced), s-xbp1
(spliced) and atf6. Each replicate for
each condition was generated from 10
pooled micro-dissected fish
gastrointestinal tracts, n≥4/group.
(E)Fish were injected with 5 pmol of
control or atf6 MO in 4.6 nl of water and
subjected to the AO tube assay. Values
were pooled from two independent
experiments, n≥29/group. veh, vehicle-
only group; glaf, glafenine-treated
group; G+D, group treated with
glafenine plus DALDA. Right: RT-PCR for
atf6 in morpholino-injected fish, at 6
dpf. Wild-type band is at 180 bp, the
morphant with an intron-1 inclusion is
at 314 bp. Representative of triplicate
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In summary, our findings show that the zebrafish represents a
powerful model for the study of cellular and molecular events
associated with the intestinal injury response and that human-
relevant drugs (DALDA, NSAIDs) have bioactive effects in this
vertebrate system. We established a novel zebrafish larvae model
of epithelial damage through chemical induction of cell stress and
impairment of organelle stress responses. We further demonstrated
that the MOR agonist DALDA rescues this intestinal damage by
potentiating the appropriate adaptive UPR responses. This novel
model of intestinal injury in zebrafish can be utilized to explore
the burgeoning field of organelle stress-induced intestinal
inflammation and to identify novel targets applicable to human
disease.
METHODS
Fish husbandry, zebrafish lines and drugs
All experiments using zebrafish were performed using protocols
approved by the Animal Studies Committee of the University of
North Carolina at Chapel Hill. Zebrafish were maintained as
previously described (Flynn et al., 2009). All experiments were
performed on zebrafish at 5.5-6 dpf. Fish were plated into 10-cm
diameter Petri dishes, with 20 ml gnotobiotic zebrafish medium
(GZM) (Pham et al., 2008), to a maximum of 20 fish/plate the day
of the experiment. All drugs (glafenine plus any therapeutics) were
administered simultaneously to the water for the indicated period
of time. Isovolumetric vehicle controls were used for all
experiments. Wild-type TL zebrafish were used for most assays in
these studies. Blood flow analysis was performed with
Tg(gata1:dsRed)sd2;(kdr1:EGFP)s843 (Traver et al., 2003; Jin et al.,
2005) zebrafish. NF-B activation was assessed with
Tg(NFkB:EGFP)nc1 zebrafish (Kanther et al., 2011). Glafenine
(Sigma-Aldrich, St Louis, MO) was dissolved in dimethyl sulfoxide
(DMSO), and administered at 25 M final concentration for all
experiments unless otherwise noted. DALDA ([D-Arg2,Lys4]-
dermorphin-(1-4)-amide; US Biological; Swampscott, MA) was
administered at 10 M. Indomethacin and Naloxone were obtained
from Sigma-Aldrich. Sc-560, Ns-398 and dmPGE2 were obtained
from Cayman Chemicals (Ann Arbor, MI); R-spondin1, hIGF1 and
mEGF were obtained from R&D Systems (Minneapolis, MN); Q-
VD-Oph was obtained from BioVision (Mountain View, CA).
AO tube assay
Fish were submerged in a 1 g/ml solution of AO (Sigma-Aldrich)
and were then anesthetized in 0.017% tricaine and mounted in 3%
methylcellulose for visualization using a Leica MZ16F fluorescence
stereomicroscope with a dsRed filter. Larvae were scored for the
presence of an AO-positive tube extending from the intestine out
of the cloaca, or for the presence of a strong red signal in intestinal
segment 2. Zebrafish with one of these two characteristics were
deemed ‘positive’.
Fish imaging and fluorescence quantification
Live zebrafish were anesthetized with 0.017% tricaine (MS-222;
Sigma-Aldrich), mounted on 3% methylcellulose and imaged with
a Leica MZ16F fluorescence stereomicroscope. Within a given
experiment, exposure times and magnifications were held constant.
Relative fluorescence intensity was determined with NIH ImageJ
(Abramoff et al., 2004), using equal-sized boxes for the region of
interest (ROI).
Histology and immunohistochemistry
Larvae were collected and fixed in 4% paraformaldehyde in PBS
overnight, then transferred to 70% ethanol for another 24 hours.
Fish were then embedded axially in 1% agarose and paraffin
embedded. Fish were serially sectioned axially and the distance from
the cloaca of each section was established based on section
thickness and section number, to determine the section being
viewed. We developed a histological scoring system in conjunction
with a veterinary pathologist (supplementary material Fig. S2A),
using only segment 2 sections due to their more consistent
histological presentation. Histological scores were verified by a
blinded pathologist.
Immunohistochemistry for activated caspase 3 (R&D Systems) was
performed as described (Trotter et al., 2009). 5-Ethynyl-2-
deoxyuridine (EdU) staining was performed using the EdU Click-iT
kit (Invitrogen; Carlsbad, CA), according to manufacturer’s protocol,
with a final EdU concentration of 15 g/ml. Fish were exposed to
EdU for the same duration as glafenine and any other treatments
(12 hours). Brightfield histological images were taken on an Olympus
IX70 (Olympus; Center Valley, PA) with the default Olympus DP
Controller software. An Olympus UpLan Fl 40, 0.75 NA objective
Fig. 10. Schematic of glafenine-induced intestinal injury in zebrafish and
MOR-mediated protection. Glafenine induces organelle stress and the UPR
response. However, this process is halted with loss of downstream gene
induction, leading to inefficient UPR and induction of IEC apoptosis. In the
presence of DALDA, glafenine-mediated blockade of the UPR process is
restored and autophagy is successfully completed, resulting in reduced IEC
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was used. For fluorescence images, a Zeiss 710 microscope with an
oil immersion, 40, 1.4 NA objective was used (Carl Zeiss;
Thornwood, NY). Zeiss Zen 2009 software was used for image
acquisition. All images were acquired at room temperature.
Electron microscopy
Zebrafish were collected, euthanized with tricaine (0.083%), and
immersion-fixed in 2% formaldehyde, 2.5% glutaraldehyde, 0.1 M
sodium cacodylate buffer, pH 7.4, overnight to several days at 4°C.
Following post-fixation for 1 hour in potassium ferrocyanide-
reduced osmium (Russell and Burguet, 1977), specimens were
dehydrated through a graded series of ethanol and embedded in
Polybed 812 epoxy resin (Polysciences, Warrington, PA). Transverse
1-m sections were cut at several locations along the gut, stained
with 1% toluidine blue and 1% sodium borate and examined by
light microscopy to confirm the ROI. Ultrathin sections were cut
with a diamond knife (70-80 nm thickness), mounted on 200 mesh
copper grids and stained with 4% aqueous uranyl acetate for 15
minutes followed by Reynolds’ lead citrate for 8 minutes (Reynolds,
1963). The sections were analyzed using a LEO EM-910
transmission electron microscope (Carl Zeiss SMT, Peabody, MA),
operating at an accelerating voltage of 80 kV. Digital images were
taken using a Gatan Orius SC 1000 CCD Camera and
DigitalMicrograph 3.11.0 software (Gatan, Pleasanton, CA). All
images were acquired at room temperature.
Oral micro-gavage and barrier function assay
Wild-type TL zebrafish larvae at 6 dpf were pretreated in a Petri
dish containing 20 ml of GZM plus 0.1 mM phenylthiourea (PTU;
to inhibit melanin synthesis) with glafenine (25 M) or the
equivalent amount of the DMSO vehicle control (0.025% v/v) for
1 or 3 hours at 25°C. Following treatment, larvae were gavaged as
previously described (Cocchiaro and Rawls, 2012) with 1% TxR-
dextran (10,000 molecular weight, D1863; Invitrogen/Molecular
Probes) or 1% TxR-dextran plus 20 mM EDTA (positive control).
Briefly, larvae were anesthetized in 0.026% tricaine and mounted
in 3% methylcellulose layered on an agarose injection mold to
position the larvae for gavage and hold them gently in place.
Borosilicate glass capillary needles specifically designed for gavage
were clipped as bluntly as possible. Using a Drummond Nanoject
II microinjection apparatus and stereomicroscope, gavage needles
were carefully manoeuvred into the mouths of anesthetized larvae,
through the esophagus, and just inside the anterior bulb of the
intestine by gently depressing the esophageal sphincter. The dextran
gavage solution (4.6 nl on the slow setting) was administered into
the anterior bulb. Following gavage, fish were moved to fresh GZM-
medium, washed gently to remove methylcellulose, and revived
from anesthesia. At 15-20 minutes post-gavage, larvae were re-
anesthetized, mounted in 3% methylcellulose on top of a 3%
agarose block (to reduce reflection glare) and imaged on a Leica
M205C fluorescence stereomicroscope. The same magnification
and gain settings were used for all images. ImageJ software was
used to quantitate mean relative fluorescence in an ROI in the larvae
trunk above the posterior intestine (trunk ROI) and an ROI outside
of the fish (background ROI). To ensure consistency in
measurement, the posterior side of the trunk ROI was always
aligned with the end of cloaca just above the intestine. GraphPad
Prism 5.0 was used for graphs and statistical analysis. The assay
was also performed for larvae pretreated for longer at 12-14 hours
(data not shown).
RT-PCR
Total RNA was isolated from either whole zebrafish larvae or
microdissected digestive tracts using an Ambion Purelink Kit
(Invitrogren) according to manufacturer’s protocol and RT-PCR
was performed as described (Kanther et al., 2011) using a ABI Prism
HT7700. Specificity and linearity of amplification for each primer
set was determined by melting curve analysis and calculation of
the slope from serial diluted samples. Relative fold-changes were
determined using the CT calculation method. Values were
normalized to the internal control 18S RNA. Primers: atf6 (5-
CTGTGGTGAAACCTCCACCT-3 and 5-CATGGTGACCA -
CAGGAGATG-3), xbp1 (5-GGGTTGGATACCTTGGAAA-3
and 5-AGGGCCAGGGCTGTGAGTA-3), xbp1-s (5-
TGTTGCGAGACAAGACGA-3 and 5-CCTGCAC -
CTGCTGCGGACT-3), 18S (5-CACTTGTCCCTCT -
AAGAAGTTGCA-3 and 5-GGTTGATTCCGATAACG -
AACGA-3) were previously described (Cinaroglu et al., 2011;
Kanther et al., 2011). PCR for analysis of atf6 morpholino efficacy
was performed using specific primers for atf6 (5-
TAGCCTACACTTTTCACCAG-3 and 5-ATGTCGTCG -
AATTTAATGTTAG-3) and the final products visualized on 3%
agarose gel (Cinaroglu et al., 2011).
Morpholino knockdown
Zebrafish embryos at the 1- to 2-cell stage were injected with splice-
blocking MOs (GeneTools LLC) targeting atf6 (4.6 pmol/embryo,
GAGTGGGGTAAGATACACGTTCTAG; generously provided by
Kirsten Sadler Edepli, Mount Sinai School of Medicine); or standard
control MO (4.6 pmol/embryo; Gene Tools LLC) using a
Drummond Nanoject II microinjector. Efficacy of atf6 knockdown
was measured by RT-PCR.
Protein isolation and western blot analysis
Whole 6-dpf zebrafish were euthanized with 0.083% tricaine and
homogenized for 15 seconds with a Polytron in 200 l cold RIPA
buffer containing proteinase inhibitors (Complete Mini; Roche
Diagnostics, Penzberg, Germany), phosphatase inhibitor cocktail
2 at a 1:100 dilution (Sigma-Aldrich) and 1 mM
phenylmethanesulfonyl fluoride (PMSF; Sigma-Aldrich).
Afterwards, lysates were diluted 1:1 with 2 Laemmli buffer.
Proteins (30 g, quantified by Bradford assay) were separated
using 10% SDS-PAGE and transferred to nitrocellulose
membranes. Blots were then probed with antibodies to BiP
(1:3000; Sigma-Aldrich) and -actin (1:1000; MP Biomedical;
Solon, OH). Antibodies were diluted in 5% dry milk in 0.1% Tris-
buffered saline containing Tween-20 (TBST). Blots were then
washed three times for 5 minutes in the 5% milk-TBST solution
and then incubated with an appropriate horse-radish-peroxidase-
conjugated secondary antibody (1:5000; GE Healthcare,
Piscataway, NJ) for 30 minutes. Proteins were detected by
chemiluminescence.
Statistical analyses
Statistical analyses were performed using GraphPad PRISM version
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were done with a two-way analysis of variance (ANOVA). Histology
post-tests and further comparisons made between zebrafish were
analyzed using a Mann-Whitney U-test at a 95% confidence
interval, unless otherwise noted in the figure legend. Relative
fluorescence data and EdU cell counting were compared with
Student’s t-tests, at a 95% confidence interval. All graphs depict
mean ± s.e.m. Experiments were considered statistically significant
if P<0.05. For all figures *P<0.05, **P<0.01 and ***P<0.001, unless
otherwise noted.
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